Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

PET/CT and SPECT/CT To Plan and Monitor the Treatment of Cancer

The Johns Hopkins University School of Medicine

Course Directors: Henry N. Wagner, Jr., MD and Richard L. Wahl, MD

The precise tailoring of treatment for patients with cancer is an unmet challenge. The goal is to only administer treatments that have a high probability of being effective. Imaging with PET/CT and SPECT/CT provides methods that will help achieve this goal. The program covers the current clinical challenges, the new emerging answers from imaging, and how these methods can be applied to patient care.

Short descriptions of the fundamentals of maximizing the performance of these procedures are presented and a greater emphasis is put on interpretation of the studies. Johns Hopkins physicians and visiting experts describe how to use PET/CT and SPECT/CT to help solve the problems encountered when treating patients, and nuclear medicine physicians with extensive experience using these techniques give insight into how best to tailor the studies for patients with various types of cancer.


 
CREDITS NA
CE RELEASE NA
CE EXPIRE NA
 
Item No Media (Can't decide on a format?) Price Purchase
575DD
Video - DVD: 8 DVDs packaged in a convenient carrying case, comprehensive program syllabus, program evaluation
$495.00
575AUP
Additional User Package: Package: comprehensive syllabus, program evaluation (initial video purchase required)
$125.00
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Kyle Jackson at 1-800-952-0690 x3075.
 

Target Audience


This program is intended for nuclear physicians, radiologists and others who care for patients with cancer.
 
 

Topics & Speakers


Recent Advances in Molecular Imaging
Henry N. Wagner Jr., MD

Overview of Current Approaches to Cure Cancer: Why We Succeed and Why We Fail
William Matsui, MD

Imaging Biomarkers in Response to Cancer Treatment
Daniel C. Sullivan, MD

STANDARDS OF ASSESSMENT OF TUMOR RESPONSE

Anatomical Imaging: The WHO and RECIST Response Criteria
Stephen J. Gwyther, FRCS, FRCR

PET IMAGING: Emerging Criteria to Determine Response to Treatment
Wolfgang A. Weber, MD

TECHNICAL CONSIDERATIONS IN RESPONSE ASSESSMENT ILLUSTRATED WITH PATIENT STUDIES

Obtaining Reliable Anatomical Data
Stephen J. Gwyther, FRCS, FRCR

Obtaining Reliable Quantitative PET/CT Data
Wolfgang A. Weber, MD

Obtaining Reliable Quantitative SPECT/CT Data
Eric Frey, PhD

Planning Radiation Treatment
Perry W. Grigsby, MD

INDIVIDUALIZING PATIENT TREATMENT

Medical Therapies for Breast Cancer
Antonio C. Wolff, MD, FACP

Planning and Monitoring Treatment of Breast Cancer with PET/CT
Richard L. Wahl, MD

Clinical Challenges in Patients with Esophageal Cancer
Michael K. Gibson, MD

Planning and Monitoring Treatment of Esophageal Cancer with PET/CT
Wolfgang A. Weber, MD

Clinical Challenges in Treating Patients with Ovarian Cancer
Robert E. Bristow, MD

LYMPHOMA
How Imaging Helps in the Individualization of Radio-immunotherapy Doses for I-131 and Y-90 Anti-CD-20 Therapy
Richard L. Wahl, MD

PROBLEMS AND SOLUTIONS IN THERAPY ASSESSMENT

A Radiation Oncologist’s Use of PET in Patients with Cervical Cancer
Perry W. Grigsby, MD

Clinical Challenges in Treating Patients With Lung Cancer
Rosalyn Juergens, MD

Measuring Response to Treatment in Patients with Lung Cancer
Hubert J. Vesselle, MD, PhD

ADVANCES ON THE HORIZON

Imaging Tumor Hypoxia
Farrokh Dehdashti, MD

Imaging Tumor Proliferation
Hubert J. Vesselle, MD, PhD

Imaging Hormone Receptors
Farrokh Dehdashti, MD

Course Directors

Henry N. Wagner, Jr., MD
Professor Emeritus of Medicine and Radiology; Professor of Environmental Health Sciences; Director, Division of Radiation Health Sciences, Johns Hopkins Bloomberg School of Public Health

Richard L. Wahl, MD
Professor of Radiology and Oncology; Henry N. Wagner, Jr., M.D. Professor of Nuclear Medicine; Director, Division of Nuclear Medicine/PET, The Johns Hopkins School of Medicine

Johns Hopkins Faculty

Robert E. Bristow, MD
Associate Professor and Director, The Kelly Gynecologic Oncology Service Department of Gynecology and Obstetrics

Eric Frey, PhD
Associate Professor of Radiology and Environmental Health Science, Bloomberg School of Public Health

Michael K. Gibson, MD
Assistant Professor of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Rosalyn Juergens, MD
Thoracic Clinical Oncology Fellow

William Matsui, MD
Assistant Professor of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Antonio C. Wolff, MD, FACP
Associate Professor of Oncology, Breast Cancer Program The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Visiting Faculty

Farrokh Dehdashti, MD
Professor of Radiology, Mallinckrodt Institute of Radiology, St. Louis, Missouri

Perry W. Grigsby, MD
Professor of Radiation Oncology/Nuclear Medicine and Gynecologic Oncology, Mallinckrodt Institute of Radiology, St. Louis, Missouri

Stephen J. Gwyther, FRCS, FRCR
Department of Medical Imaging, East Surrey Hospital, Redhill, Surrey, United Kingdom

Daniel C. Sullivan, MD
Associate Director, National Cancer Institute, Cancer Imaging Program, Bethesda, Maryland

Hubert J. Vesselle, MD, PhD
Associate Professor of Radiology, University of Washington, Seattle, Washington

Wolfgang A. Weber, MD
Associate Professor of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California


 
 

Learning Objectives


After viewing this program, participants should be able to:

  • Be familiar with the basic techniques used to perform a PET/CT or SPECT/CT study and the steps necessary to perform several studies on the same patient and obtain useful quantitative response data
  • Gain perspective about which patients benefit the most from these studies to assess response to treatment
  • Learn how Johns Hopkins physicians are using PET/CT and SPECT/CT studies to meet the challenges faced when treating patients
  • Understand how this field is rapidly developing and gain insight into the exciting areas that lie ahead

 
 

Accreditation Statement


The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
 
 

Faculty Disclosure


It is the policy of The Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials.